Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Biopharmaceutical Manufacturing Market Report by Cell Culture (Mammalian Cell Culture, Microbial Cell Culture), Class (Monoclonal Antibodies, Recombinant Proteins, Interferon, Granulocyte Colony-Stimulating Factor (G-CSF), Erythropoietin, Recombinant Human Insulin, Vaccines, Human Growth Hormones (HGH)), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A724
Buy Now
1 Preface
2 Research Methodology and Market Definitions
3 Executive Summary
4 Global Biopharmaceutical Market: Key Trends
4.1 Biopharmaceuticals are Growing Faster than Small Molecule Drugs
4.2 Growth of Biosimilars will Push Volumes and Introduce New Players in this Market
4.3 A Rich Biopharmaceutical Pipeline will Drive the Capacity Demand in the Coming Years
4.4 Increasing Trends in Mergers and Acquisitions will Increase Redundant Capacities
4.5 Increasing Focus on Personalized Medicines and High Value Low Volume Markets
4.6 Higher Titers will Reduce Capacity Demand
4.7 Growth in the Use of Cost Effective Disposable Technologies
4.8 Despite Sufficient Global Capacity, Its Uneven Distribution will Continue to Spur Demand
5 Global Biopharmaceutical Market: Industry Performance
5.1 Current and Historical Sales Trends
5.2 Market Breakup by Region
5.3 Market Breakup by Expression Systems
5.4 Market Breakup by Product Type
5.5 Market Outlook
5.6 SWOT Analysis
5.6.1 Strengths
5.6.2 Weaknesses
5.6.3 Opportunities
5.6.4 Threats
5.7 Value Chain Analysis
5.8 Porter’s Five Forces Analysis
5.8.1 Overview
5.8.2 Bargaining Power of Buyers
5.8.3 Bargaining Power of Suppliers
5.8.4 Degree of Competition
5.8.5 Threat of New Entrants
5.8.6 Threat of Substitutes
6 Regional Biopharmaceutical Market Analysis
6.1 United States
6.1.1 Current and Historical Sales Trends
6.1.2 Market Outlook
6.2 Canada
6.2.1 Current and Historical Sales Trends
6.2.2 Market Outlook
6.3 United Kingdom
6.3.1 Current and Historical Sales Trends
6.3.2 Market Outlook
6.4 Germany
6.4.1 Current and Historical Sales Trends
6.4.2 Market Outlook
6.5 France
6.5.1 Current and Historical Sales Trends
6.5.2 Market Outlook
6.6 Italy
6.6.1 Current and Historical Sales Trends
6.6.2 Market Outlook
6.7 Spain
6.7.1 Current and Historical Sales Trends
6.7.2 Market Outlook
6.8 Russia
6.8.1 Current and Historical Sales Trends
6.8.2 Market Outlook
6.9 Brazil
6.9.1 Current and Historical Sales Trends
6.9.2 Market Outlook
6.10 Australia
6.10.1 Current and Historical Sales Trends
6.10.2 Market Outlook
7 Global Biopharmaceutical Manufacturing Industry
7.1 Current and Historical Manufacturing Capacity Trends
7.2 Impact of COVID-19
7.3 Market Breakup by Region
7.3.1 North America
7.3.1.1 Current and Historical Manufacturing Capacity Trends
7.3.1.2 Market Outlook
7.3.2 Europe
7.3.2.1 Current and Historical Manufacturing Capacity Trends
7.3.2.2 Market Outlook
7.3.3 Asia
7.3.3.1 Current and Historical Manufacturing Capacity Trends
7.3.3.2 Market Outlook
7.4 Market Breakup by Cell Culture
7.4.1 Mammalian Cell Culture
7.4.1.1 Key Market Drivers
7.4.1.2 Current and Historical Sales Trends
7.4.1.3 Current and Historical Manufacturing Capacity Trends
7.4.1.4 Market Breakup by Region
7.4.1.5 Market Breakup by Product Type
7.4.1.6 Key Players
7.4.1.7 Market Outlook
7.4.2 Microbial Cell Culture
7.4.2.1 Key Market Drivers
7.4.2.2 Current and Historical Sales Trends
7.4.2.3 Current and Historical Manufacturing Capacity Trends
7.4.2.4 Market Breakup by Product
7.4.2.5 Market Breakup by Region
7.4.2.6 Key Players
7.4.2.7 Market Outlook
7.5 Market Breakup by Class
7.5.1 Monoclonal Antibodies
7.5.1.1 Current and Historical Sales Trends
7.5.1.2 Market Outlook
7.5.2 Recombinant Proteins
7.5.2.1 Current and Historical Sales Trends
7.5.2.2 Market Outlook
7.5.3 Interferon
7.5.3.1 Current and Historical Sales Trends
7.5.3.2 Market Outlook
7.5.4 Granulocyte Colony-Stimulating Factor (G-CSF)
7.5.4.1 Current and Historical Sales Trends
7.5.4.2 Market Outlook
7.5.5 Erythropoietin
7.5.5.1 Current and Historical Sales Trends
7.5.5.2 Market Outlook
7.5.6 Recombinant Human Insulin
7.5.6.1 Current and Historical Sales Trends
7.5.6.2 Market Outlook
7.5.7 Vaccines
7.5.7.1 Current and Historical Sales Trends
7.5.7.2 Market Outlook
7.5.8 Human Growth Hormones (HGH)
7.5.8.1 Current and Historical Sales Trends
7.5.8.2 Market Outlook
7.6 Market Outlook
8 Competitive Landscape
8.1 Market Breakup by Manufacturer Type
8.1.1 Product Companies
8.1.2 Contract Manufacturers
8.2 Key Player Profiles
8.2.1 AbbVie Inc.
8.2.1.1 Company Overview
8.2.1.2 Key Financials
8.2.2 Amgen Inc.
8.2.2.1 Company Overview
8.2.2.2 Key Financials
8.2.3 Biogen Inc.
8.2.3.1 Company Overview
8.2.3.2 Key Financials
8.2.4 Eli Lilly and Company
8.2.4.1 Company Overview
8.2.4.2 Key Financials
8.2.5 F. Hoffmann-La Roche Ltd.
8.2.5.1 Company Overview
8.2.5.2 Key Financials
8.2.6 Johnson & Johnson Services Inc.
8.2.6.1 Company Overview
8.2.6.2 Key Financials
8.2.7 Merck & Co. Inc.
8.2.7.1 Company Overview
8.2.7.2 Key Financials
8.2.8 Novo Nordisk A/S
8.2.8.1 Company Overview
8.2.8.2 Key Financials
8.2.9 Pfizer Inc.
8.2.9.1 Company Overview
8.2.9.2 Key Financials
8.2.10 Sanofi S.A.
8.2.10.1 Company Overview
8.2.10.2 Key Financials
List of Figures
Figure 4-1: Global: Companies Manufacturing or Developing Active Substances for Follow-on Biologics (in no’s)
Figure 4-2: Global: Biopharmaceutical Products: Distribution by Production Technology (in no’s)
Figure 4-3: Global: Biopharmaceuticals: Mergers and Acquisitions Transaction Value (in US$ Billion)
Figure 4-4: Global: Orphan Drug Market: Designated vs Approvals (in no’s), 2018-2023
Figure 4-5: Global: Personalized Medicine Market (in US$ Billion), 2018 and 2023
Figure 4-6: Increase in Titers and Reduction in Capacity Utilization Rate (in %), 2018 and 2023
Figure 4-7: Disposable (Single Use) vs Stainless Steel Bioreactors
Figure 4-8: United States and Western Europe: Capacity Expansion
Figure 5-1: Global: Biopharmaceutical Market: Sales Trend (in US$ Billion), 2018-2023
Figure 5-2: Global: Biopharmaceutical Market: Breakup by Region (in %), 2023
Figure 5-3: Global: Biopharmaceutical Market: Breakup by Various Expression Systems (in %), 2023
Figure 5-4: Global: Biopharmaceutical Market: Expression Systems (Respondents’ Trends), 2018-2023
Figure 5-5: Global: Biopharmaceutical Market: Breakup by Drug Sales (in %), 2023
Figure 5-6: Global: Biopharmaceutical: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 5-7: Global: Biopharmaceutical Industry: SWOT Analysis
Figure 5-8: Global: Biopharmaceutical Industry: Value Chain Analysis
Figure 5-9: Global: Biopharmaceutical Industry: Porter’s Five Forces Analysis
Figure 6-1: United States: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-2: United States: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-3: Canada: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-4: Canada: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-5: United Kingdom: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-6: United Kingdom: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-7: Germany: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-8: Germany: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-9: France: Biopharmaceutical Market: Sales Trend (in Million US$), 2018-2023
Figure 6-10: France: Biopharmaceutical Market: Sales Trend Forecast (in Million US$), 2024-2032
Figure 6-11: Italy: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-12: Italy: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-13: Spain: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-14: Spain: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-15: Russia: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-16: Russia: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-17: Brazil: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-18: Brazil: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 6-19: Australia: Biopharmaceutical Market: Sales Trend (in US$ Million), 2018-2023
Figure 6-20: Australia: Biopharmaceutical Market: Sales Trend Forecast (in US$ Million), 2024-2032
Figure 7-1: Global: Biopharmaceutical Manufacturing: Capacity Trends (in Kilo Liters), 2018-2023
Figure 7-2: Global: Biopharmaceuticals Manufacturing: Capacity Breakup by Region (in %), 2023
Figure 7-3: North America: Biopharmaceuticals Manufacturing: Capacity Trend (in Kilo Liters), 2018-2023
Figure 7-4: North America: Biopharmaceuticals Manufacturing: Capacity Trend Forecast (in Kilo Liters), 2024-2032
Figure 7-5: Europe: Biopharmaceuticals Manufacturing: Capacity Trend (in Kilo Liters), 2018-2023
Figure 7-6: Europe: Biopharmaceuticals Manufacturing: Capacity Trend Forecast (in Kilo Liters), 2024-2032
Figure 7-7: Asia: Biopharmaceuticals Manufacturing: Capacity Trend (in Kilo Liters), 2018-2023
Figure 7-8: Asia: Biopharmaceuticals Manufacturing: Capacity Trend Forecast (in Kilo Liters), 2024-2032
Figure 7-9: Global: Mammalian Products: Sales Trend (in US$ Billion), 2018-2023
Figure 7-10: Global: Mammalian Cell Culture: Capacity Trend (in Kilo Liters), 2018-2023
Figure 7-11: Global: Mammalian Cell Culture: Capacity Utilization Trend (in %), 2018-2023
Figure 7-12: Global: Mammalian Cell Culture: Capacity Trends by Region (in Kilo Liters), 2018-2023
Figure 7-13: Global: Mammalian Cell Culture: Demand Breakup of Commercial Antibody Products (in %), 2023
Figure 7-14: Global: Mammalian Cell Culture: Market Breakup by Key Players (in %), 2023
Figure 7-15: Global: Mammalian Products: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-16: Global: Mammalian Cell Culture: Capacity Trend Forecast (in Kilo Liters), 2024-2032
Figure 7-17: Global: Mammalian Cell Culture: Capacity Trends Forecast by Region (in Kilo Liters), 2024-2032
Figure 7-18: Global: Microbial Products: Sales Trend (in US$ Billion), 2018-2023
Figure 7-19: Global: Microbial Cell Culture: Capacity Trend (in Kilo Liters), 2018-2023
Figure 7-20: Global: Microbial Cell Culture: Capacity (Commercial Volume) Trend (in Kilo Liters), 2018-2023
Figure 7-21: Global: Microbial Cell Culture: Capacity (Clinical Volume) Trend (in Kilo Liters), 2018-2023
Figure 7-22: Global: Microbial Cell Culture: Capacity Utilization Trend (in %), 2018-2023
Figure 7-23: Global: Microbial Cell Culture: Demand Breakup of Commercial Products (in %), 2023
Figure 7-24: Global: Microbial Cell Culture: Capacity (Commercial Volume) Trends by Region (in Kilo Liters), 2018-2023
Figure 7-25: Global: Microbial Cell Culture: Capacity (Clinical Volume) Trends by Region (in Kilo Liters), 2018-2023
Figure 7-26: Global: Microbial Cell Culture: Market Breakup by Key Players (in %), 2023
Figure 7-27: Global: Microbial Products: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-28: Global: Microbial Products: Capacity Trend Forecast (in Kilo Liters), 2024-2032
Figure 7-29: Global: Microbial Cell Culture: Capacity (Commercial Volume) Trends Forecast by Region (in Kilo Liters), 2024-2032
Figure 7-30: Global: Microbial Cell Culture: Capacity (Clinical Volume) Trends Forecast by Region (in Kilo Liters), 2024-2032
Figure 7-31: Global: Monoclonal Antibodies: Sales Trend (in US$ Billion), 2018-2023
Figure 7-32: Global: Monoclonal Antibodies: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-33: Global: Recombinant Proteins: Sales Trend (in US$ Billion), 2018-2023
Figure 7-34: Global: Recombinant Proteins: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-35: Global: Interferon: Sales Trend (in US$ Billion), 2018-2023
Figure 7-36: Global: Interferon: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-37: Global: Granulocyte Colony-Stimulating Factor (G-CSF): Sales Trend (in US$ Billion), 2018-2023
Figure 7-38: Global: Granulocyte Colony-Stimulating Factor (G-CSF): Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-39: Global: Erythropoietin: Sales Trend (in US$ Billion), 2018-2023
Figure 7-40: Global: Erythropoietin: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-41: Global: Recombinant Human Insulin: Sales Trend (in US$ Billion), 2018-2023
Figure 7-42: Global: Recombinant Human Insulin: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-43: Global: Vaccines: Sales Trend (in US$ Billion), 2018-2023
Figure 7-44: Global: Vaccines: Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-45: Global: Human Growth Hormones (HGH): Sales Trend (in US$ Billion), 2018-2023
Figure 7-46: Global: Human Growth Hormones (HGH): Sales Trend Forecast (in US$ Billion), 2024-2032
Figure 7-47: Global: Biopharmaceutical Manufacturing: Capacity Trend Forecast (In Kilo Liters), 2024-2032
Figure 8-1: Global: Biopharmaceutical Manufacturing: Capacity Breakup by Manufacturer Type (in %), 2023
Figure 8-2: Global: Biopharmaceutical Manufacturing: Capacity Breakup Forecast by Manufacturer Type (in %), 2032
Figure 8-3: Global: Biopharmaceutical Product Companies: Capacity Trend (in Kilo Liters), 2018-2023
Figure 8-4: Global: Biopharmaceutical Product Companies: Capacity Trend Forecast (in Kilo Liters), 2024-2032
Figure 8-5: Global: Biopharmaceutical CMOs: Capacity Trend (in Kilo Liters), 2018-2023
Figure 8-6: Global: Biopharmaceutical CMOs: Capacity Trend Forecast (in Kilo Liters), 2024-2032
Figure 8-7: AbbVie Inc.: Sales Value Trend (in Billion US$), 2014-2018
Figure 8-8: AbbVie Inc.: Revenue Breakup by Region (in %), 2019
Figure 8-9: Amgen Inc.: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-10: Amgen Inc.: Revenue Breakup by Region (in %), 2019
Figure 8-11: Biogen Inc.: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-12: Biogen Inc.: Revenue Breakup by Region (in %), 2019
Figure 8-13: Eli Lilly and Company: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-14: Eli Lilly and Company: Revenue Breakup by Region (in %), 2019
Figure 8-15: F. Hoffmann-La Roche Ltd.: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-16: F. Hoffmann-La Roche Ltd.: Revenue Breakup by Region (in %), 2019
Figure 8-17: Johnson & Johnson Services Inc.: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-18: Johnson & Johnson Services Inc.: Revenue Breakup by Region (in %), 2019
Figure 8-19: Merck & Co. Inc.: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-20: Merck & Co. Inc.: Revenue Breakup by Region (in %), 2019
Figure 8-21: Novo Nordisk A/S: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-22: Novo Nordisk A/S: Revenue Breakup by Region (in %), 2019
Figure 8-23: Pfizer Inc.: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-24: Pfizer Inc.: Revenue Breakup by Region (in %), 2019
Figure 8-25: Sanofi S.A.: Sales Value Trend (in Billion USD), 2014-2018
Figure 8-26: Sanofi S.A.: Revenue Breakup by Region (in %), 2019
List of Tables
Table 4-1: Global: Small Molecule Sales vs. Biopharmaceutical Sales (in Billion US$), 2018-2023
Table 8-1: AbbVie Inc.: Financial Data (2014-2018)
Table 8-2: Amgen Inc.: Financial Data (2014-2018)
Table 8-3: Biogen Inc.: Financial Data (2014-2018)
Table 8-4: Eli Lilly and Company: Financial Data (2014-2018)
Table 8-5: F. Hoffmann-La Roche Ltd.: Financial Data (2014-2018)
Table 8-6: Johnson & Johnson Services Inc.: Financial Data (2014-2018)
Table 8-7: Merck & Co. Inc.: Financial Data (2014-2018)
Table 8-8: Novo Nordisk A/S: Financial Data (2014-2018)
Table 8-9: Pfizer Inc.: Financial Data (2014-2018)
Table 8-10: Sanofi S.A.: Financial Data (2014-2018)
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More
IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.
Read More
I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested
Read More
Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.
Read More
The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.
Read More
I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you
Read More
The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.
Read More
One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.
Read More
We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.
Read More
The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.
Read More
The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.
Read More
The report is excellent and has good amount of data and our team is extremely happy with the information provided.
Read More
Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.
Read More